The youth vaping epidemic has been driven in part by the addictiveness of nicotine and its impact on the developing brain. However, the U.S. Food & Drug Administration has been slow to regulate these products to protect youth. Moreover, an emerging class of vaping products that do not contain nicotine but are marketed with wellness and vaping cessation claims present new regulatory challenges.